相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MAIT cells: a novel therapeutic target for alcoholic liver disease?
Bin Gao et al.
GUT (2018)
Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease
Antonio Riva et al.
GUT (2018)
Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes
Lucas A. Horn et al.
CANCER IMMUNOLOGY RESEARCH (2018)
PD-1 pathway and its clinical application: A 20 year journey after discovery of the complete human PD-1 gene
Kristin Nicole Berger et al.
GENE (2018)
Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study
Ya Mei Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The TIM3-Gal9 immune checkpoint axis is inter-linked with severity of Alcoholic Liver Disease
A. Riva et al.
JOURNAL OF HEPATOLOGY (2018)
Antibodies to watch in 2018
Helene Kaplon et al.
MABS (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
Aaron Goodman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA
Nikhil Vergis et al.
GASTROENTEROLOGY (2017)
Targeting Immune Cell Checkpoints during Sepsis
Naeem K. Patil et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Control of NK Cell Activation by Immune Checkpoint Molecules
Asma Beldi-Ferchiou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination
Arash Memarnejadian et al.
JOURNAL OF IMMUNOLOGY (2017)
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J. Kaunitz et al.
LABORATORY INVESTIGATION (2017)
New metrics for the Lancet Standing Commission on Liver Disease in the UK
Roger Williams et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Noninvasive detection of acute renal allograft rejection by measurement of soluble Tim-3 in urine
Dajin Chen et al.
MOLECULAR MEDICINE REPORTS (2017)
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman et al.
NATURE COMMUNICATIONS (2017)
Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
Xinxin Zhu et al.
ONCOTARGET (2017)
Modulation of Tim-3 Expression by Antigen-Dependent and -Independent Factors on T Cells from Patients with Chronic Hepatitis B Virus Infection
Jie Dong et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
Trial watch: Immune checkpoint blockers for cancer therapy
Claire Vanpouille-Box et al.
ONCOIMMUNOLOGY (2017)
Resistance to PD1/PDL1 checkpoint inhibition
Jake S. O'Donnell et al.
CANCER TREATMENT REVIEWS (2017)
Biomarkers of response to PD-1/PD-L1 inhibition
Saman Maleki Vareki et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Targeting NK-cell checkpoints for cancer immunotherapy
Aura Muntasell et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
Sara Gandini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The challenges of multi-drug-resistance in hepatology
Javier Fernandez et al.
JOURNAL OF HEPATOLOGY (2016)
Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
Andriani C. Patera et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
role of Tim-3 in hepatitis B virus infection: An overview
Yuan Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study
Rui Shao et al.
CRITICAL CARE (2016)
Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus
Lekh N. Dahal et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Current views on the mechanisms of immune responses to trauma and infection
Aneta Malgorzata Binkowska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2015)
Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis
Lee J. L. Markwick et al.
GASTROENTEROLOGY (2015)
Identifying Molecular Targets to Improve Immune Function in Alcoholic Hepatitis
Ramon Bataller et al.
GASTROENTEROLOGY (2015)
Alcoholic liver disease: mechanisms of injury and targeted treatment
Alexandre Louvet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Prednisolone or Pentoxifylline for Alcoholic Hepatitis
Mark R. Thursz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes
F. Ren et al.
TISSUE ANTIGENS (2015)
T cell exhaustion during persistent viral infections
Shannon M. Kahan et al.
VIROLOGY (2015)
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
JOURNAL OF HEPATOLOGY (2015)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Rajiv Jalan et al.
JOURNAL OF HEPATOLOGY (2014)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis
Roger Williams et al.
LANCET (2014)
Immune dysfunction in cirrhosis
Nora Sipeki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
B-cell exhaustion in HIV infection: the role of immune activation
Susan Moir et al.
CURRENT OPINION IN HIV AND AIDS (2014)
The changing immune system in sepsis Is individualized immuno-modulatory therapy the answer?
Jonathan S. Boomer et al.
VIRULENCE (2014)
The Soluble Form of CTLA-4 from Serum of Patients with Autoimmune Diseases Regulates T-Cell Responses
Rita Simone et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A Soluble Form of CD80 Enhances Antitumor Immunity by Neutralizing Programmed Death Ligand-1 and Simultaneously Providing Costimulation
Samuel T. Haile et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes
Jonathan R. Potts et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2013)
PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model
Weimin Zhu et al.
MEDIATORS OF INFLAMMATION (2013)
Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma
Omid Hamid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Innibitory receptor expression cepencs more commantly on cifferentiation and activation than exnaustion of human CD8 T cells
Amandine Legat et al.
FRONTIERS IN IMMUNOLOGY (2013)
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Richard S. Hotchkiss et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
The Tim3-Galectin 9 Pathway Induces Antibacterial Activity in Human Macrophages Infected with Mycobacterium tuberculosis
Isabel Sada-Ovalle et al.
JOURNAL OF IMMUNOLOGY (2012)
Antigen-Independent Induction of Tim-3 Expression on Human T Cells by the Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Is Associated with Proliferation and Is Dependent on the Phosphoinositide 3-Kinase Pathway
Shariq Mujib et al.
JOURNAL OF IMMUNOLOGY (2012)
Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care
Lori F. Gentile et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2012)
B-Lymphocyte Dysfunction in Chronic HIV-1 Infection Does Not Prevent Cross-Clade Neutralization Breadth
Saikat Boliar et al.
JOURNAL OF VIROLOGY (2012)
Sepsis studies need new direction
Jonathan Cohen et al.
LANCET INFECTIOUS DISEASES (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
Lukas Baitsch et al.
PLOS ONE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Tim-3-Expressing CD4+ and CD8+ T Cells in Human Tuberculosis (TB) Exhibit Polarized Effector Memory Phenotypes and Stronger Anti-TB Effector Functions
Yueqin Qiu et al.
PLOS PATHOGENS (2012)
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Phillipp Hartmann et al.
FRONTIERS IN PHYSIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
Jonathan S. Boomer et al.
CRITICAL CARE (2012)
Dual biological effects of the cytokines interleukin-10 and interferon-γ
Cailin Moira Wilke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Anti-TIM3 Antibody Promotes T Cell IFN-γ-Mediated Antitumor Immunity and Suppresses Established Tumors
Shin Foong Ngiow et al.
CANCER RESEARCH (2011)
Immune Dysfunction and Infections in Patients With Cirrhosis
Alexander R. Bonnel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
B7-H2 Is a Costimulatory Ligand for CD28 in Human
Sheng Yao et al.
IMMUNITY (2011)
Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B
Ji Chen et al.
INFLAMMATION RESEARCH (2011)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The Search for Effective Therapy for Sepsis Back to the Drawing Board?
Derek C. Angus
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis
Xinjing Wang et al.
JOURNAL OF INFECTION (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
Emerging Tim-3 functions in antimicrobial and tumor immunity
Kaori Sakuishi et al.
TRENDS IN IMMUNOLOGY (2011)
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
Jang-June Park et al.
BLOOD (2010)
Tumor Cell Expression of Programmed Cell Death-1 Ligand 1 Is a Prognostic Factor for Malignant Melanoma
Ryosuke Hino et al.
CANCER (2010)
Tim3 binding to galectin-9 stimulates antimicrobial immunity
Pushpa Jayaraman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Kaori Sakuishi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
PD-1, a new target for sepsis treatment: better late than never
Sanna M. Goyert et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
Pavan Brahmamdam et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The 6-month abstinence rule in liver transplantation
Debbie L. Shawcross et al.
LANCET (2010)
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
Elias A. Said et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Hyun-Tak Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
Yan Zhang et al.
CRITICAL CARE (2010)
Genome-wide transcription profiling of human sepsis: a systematic review
Benjamin M. Tang et al.
CRITICAL CARE (2010)
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
William D. Hastings et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Systemic inflammatory response following acute traumatic brain injury
Jia Lu
Frontiers in Bioscience-Landmark (2009)
Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor
Alexandre Louvet et al.
GASTROENTEROLOGY (2009)
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Joseph F. Grosso et al.
JOURNAL OF IMMUNOLOGY (2009)
Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Compensatory anti-inflammatory response syndrome
Minou Adib-Conquy et al.
THROMBOSIS AND HAEMOSTASIS (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
Takeshi Azuma et al.
BLOOD (2008)
The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients
Nicholas S. Ward et al.
CLINICS IN CHEST MEDICINE (2008)
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion
Alexander Evans et al.
HEPATOLOGY (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michal Marzec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhibitory B7-family molecules in the tumour microenvironment
Weiping Zou et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Stephanie G. Downey et al.
CLINICAL CANCER RESEARCH (2007)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
Carolina Boni et al.
JOURNAL OF VIROLOGY (2007)
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection
Amalia Penna et al.
HEPATOLOGY (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion
Simona Urbani et al.
JOURNAL OF VIROLOGY (2006)
Drug therapy: Management of sepsis
Jarnes A. Russell
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Lydie Trautmann et al.
NATURE MEDICINE (2006)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality
Marcin F. Osuchowski et al.
JOURNAL OF IMMUNOLOGY (2006)
Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity
C Casati et al.
CANCER RESEARCH (2006)
Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection
T Boettler et al.
JOURNAL OF VIROLOGY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Immune reactivity is more suppressed in patients with alcoholic liver disease than in patients with virus-induced cirrhosis after CRH stimulation
V Eggers et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Constitutive and inducible expression of B7 family of ligands by human airway epithelial cells
J Kim et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Cirrhosis: Report on the 7th Meeting of the International Ascites Club
F Wong et al.
GUT (2005)
The B7 family of immune-regulatory ligands
M Collins et al.
GENOME BIOLOGY (2005)
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells
DH Munn et al.
JOURNAL OF IMMUNOLOGY (2004)
Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system
G Eissner et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
B7-h1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
J Konishi et al.
CLINICAL CANCER RESEARCH (2004)
Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses
SC Liang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
FS Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Medical progress: The pathophysiology and treatment of sepsis.
RS Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
The interaction properties of costimulatory molecules revisited
AV Collins et al.
IMMUNITY (2002)
B7 family molecules: Novel immunomodulators at the maternal-fetal interface
MG Petroff et al.
PLACENTA (2002)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Sepsis syndromes: Understanding the role of innate and acquired immunity
A Oberholzer et al.
SHOCK (2001)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
E Chuang et al.
IMMUNITY (2000)
分享论文
